RMI has partnered with iCad, the makers of ProFound AI® for digital breast tomosynthesis (3D mammography). ProFound AI reduces radiologist reading times by more than 50%, while providing a “second set of eyes” to enhance our ability to spot possibly cancerous lesions. The precision reduces the amount of call-backs and unnecessary biopsies especially for patients with dense breasts.
Dr. Hicks Introducing ProFound AI
Learn more about iCAD and this important application for RMI at https://www.icadmed.com/profoundai.html.
See also stories and news releases on https://www.rmipc.net/about-us/news-press-releases-from-rmi/.
